Multicenter phase II study of apatinib in non-triple-negative metastatic breast cancer.
Hu X, Cao J, Hu W, Wu C, Pan Y, Cai L, Tong Z, Wang S, Li J, Wang Z, Wang B, Chen X, Yu H.
Hu X, et al. Among authors: cao j.
BMC Cancer. 2014 Nov 7;14:820. doi: 10.1186/1471-2407-14-820.
BMC Cancer. 2014.
PMID: 25376790
Free PMC article.
Clinical Trial.